SINT SINTX TECHNOLOGIES INC.

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Salt Lake City, Utah, Feb. 26, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc., (“SINTX” or the “Company”) (Nasdaq: SINT), a leader in advanced ceramics for medical applications, today announced that it has, pursuant to a securities purchase agreement with institutional and accredited investors dated February 20, 2025, issued and sold 1,449,287 shares of common stock (or pre-funded warrants in lieu therof) at a purchase price of $3.45 per share (or pre-funded warrant in lieu thereof) in a private placement priced at-the-market under Nasdaq rules. In addition, the Company issued to the investors in the offering unregistered warrants (the “warrants”) to purchase up to an aggregate of 1,449,287 shares of common stock. The warrants are exercisable immediately at an exercise price of $3.32 per share and will expire five and one-half years from the date of issuance. The offering closed on February 25, 2025.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

The aggregate gross proceeds to the Company from the private placement were approximately $5 million before deducting placement agent fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for working capital purposes.

The shares of common stock, pre-funded warrants and warrants described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”) and Regulation D promulgated thereunder and, along with the shares of common stock underlying the pre-funded warrants and warrants, have not been registered under the Act or applicable state securities laws. Accordingly, the shares of common stock, the pre-funded warrants, the warrants and the shares of common stock underlying the pre-funded warrants and warrants may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (“SEC”) or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock and the shares issuable upon exercise of the pre-funded warrants and warrants.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About SINTX Technologies, Inc.

Located in Salt Lake City, Utah, SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter into new markets.

For more information on SINTX Technologies or its materials platform, visit .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to a number of risks and uncertainties. Forward-looking statements can be identified by words such as: "anticipate," "believe," "project," "estimate," "expect," "strategy,” "future," "likely," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the anticipated use of proceeds from offering. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, difficulties in commercializing ceramic technologies and development of new product opportunities. A discussion of other risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the SEC on March 27, 2024, and in SINTX’s other filings with the SEC. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report, except as required by law.

Business and Media Inquiries for SINTX:

SINTX Technologies

801.839.3502



EN
26/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SINTX TECHNOLOGIES INC.

 PRESS RELEASE

SINTX Technologies to Participate in Sidoti & Company Investor Confere...

SINTX Technologies to Participate in Sidoti & Company Investor Conference SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that management will be presenting at Sidoti & Company’s Year End Virtual Investor Conference, held December 10-11, 2025. Sidoti's Year End Virtual Investor ConferenceDates: December 10-11, 2025Presentation Date and Time: Wednesday, December 10, 2025 at 3:15 P.M. ETWebcast: To schedule a one-on-one meeting with SINTX Technologies’ management team, please email KCSA Strategic ...

 PRESS RELEASE

SINTX Technologies חותמת על הסכם אספקה עם EVONIK לייצור תרכובת סיליקון...

SINTX Technologies חותמת על הסכם אספקה עם EVONIK לייצור תרכובת סיליקון ניטריד עם PEEK עבור שתלים ייעודיים למטופלים המודפסים בתלת ממד בסיוע בינה מלאכותית ציון דרך שמאפשר ייצור מיידי של התקני SiN/PEEK בהתאמה אישית סולט לייק סיטי, יוטה, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (נאסד"ק: SINT) ("SINTX" או "החברה"), חברה לייצור קרמיקה וחומרים ביולוגיים מתקדמים, הודיעה כי חתמה על הסכם אספקה ​​עם Evonik Corporation (EVONIK), מובילה עולמית בפולימרי ביצועים גבוהים, לייצור תרכובת הסיליקון ניטריד-PEEK (SiN/PEEK) הקניינית של החברה (פטנט אמריקאי מס' 10,806,831) אשר תוכננה לייצור תו...

 PRESS RELEASE

SINTX Technologies Menandatangani Perjanjian Pasokan dengan EVONIK unt...

SINTX Technologies Menandatangani Perjanjian Pasokan dengan EVONIK untuk Memproduksi Senyawa Silikon Nitrida–PEEK untuk Implan Khusus Pasien Tertentu yang Dicetak 3D dan Didukung AI Pencapaian ini mewujudkan produksi langsung perangkat khusus SiN/PEEK SALT LAKE CITY, Utah, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” atau “Perusahaan”), perusahaan keramik dan biomaterial canggih, hari ini mengumumkan bahwa pihaknya telah menandatangani perjanjian pasokan dengan Evonik Corporation (“EVONIK”), pemimpin global dalam polimer berperforma tinggi, untuk me...

 PRESS RELEASE

シンテックス・テクノロジーズ、AI支援型3Dプリント患者特異的インプラント向け窒化ケイ素-PEEK複合材を製造する供給契約をエボニックと締結

シンテックス・テクノロジーズ、AI支援型3Dプリント患者特異的インプラント向け窒化ケイ素-PEEK複合材を製造する供給契約をエボニックと締結 この画期的な契約により、SiN/PEEKカスタムデバイスの即時生産が可能になる ユタ州ソルトレイクシティ発 , Dec. 02, 2025 (GLOBE NEWSWIRE) -- 先進セラミックスおよびバイオマテリアル企業であるシンテックス・テクノロジーズ (SINTX Technologies, Inc.)(NASDAQ: SINT)(以下「SINTX」または「同社」) は本日、高性能ポリマー分野の世界的リーダーであるエボニック (以下「エボニック」)と供給契約を締結したことを発表した。シンテックスの米国生産施設に既に設置されている設備を用いて生産される、患者特異的インプラントのAI支援付加製造向けに設計された、同社独自の窒化ケイ素-PEEK複合材 (SiN/PEEK) (米国特許第10,806,831号) を製造するために使用される。 本契約に基づき、エボニックは商業規模の生産能力を活用してシンテックスの仕様に準拠したSiN/PEEK複合材を製造し、同社はAI設計による3Dプリント式患者特異的インプラントの製造を直ちに開始できるようになる。 シンテックスでは、脊椎腫瘍切除後の整形外科・脳神経外科腫瘍患者のための椎体置換 (...

 PRESS RELEASE

SINTX Technologies, AI 적용한 3D 프린팅 환자 맞춤형 임플란트 위한 실리콘 나이트라이드–PEEK 복합소재 ...

SINTX Technologies, AI 적용한 3D 프린팅 환자 맞춤형 임플란트 위한 실리콘 나이트라이드–PEEK 복합소재 제조 위해 EVONIK과 계약 체결 SiN/PEEK 맞춤 장비 생산에 즉시 착수할 수 있게 돼 미국 유타주 솔트레이크시티, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 첨단 세라믹과 생체소재 회사인 SINTX Technologies, Inc.(나스닥명: SINT) (이하 “SINTX” 또는 “회사”)가 특허를 획득한 실리콘 나이트라이드-PEEK 복합소재(SiN/PEEK) (미국 특허 제10,806,831호)를 제조하기 위해 고성능 폴리머 분야의 글로벌 선도 기업 Evonik Corporation(“EVONIK”)과 공급 계약을 체결했다. 이 소재는 SINTX의 미국 생산 설비에 이미 설치된 장비를 활용하고 AI를 적용해 생산될 예정인 환자 맞춤형 임플란트의 적층 제조를 위해 설계되었다. 이 계약에 따라 EVONIK은 상업 규모의 생산 역량을 활용해 Sin/PEEK 복합소재를 생산하게 되며, 이에 따라 회사는 AI 설계를 바탕으로 3D 프린팅한 환자 맞춤형 임플란트 제조를 즉시 시작할 수 있게 되었다. SIN...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch